KPV 50mg — Vial Spec, Reconstitution Math & COA

Overview of the KPV 50mg Research Format

The 50mg KPV research vial is a high-yield lyophilized format formulated for laboratories conducting extensive preclinical protocols. KPV is a tripeptide comprising the amino acid sequence Lysine-Proline-Valine (Lys-Pro-Val), corresponding to the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). In molecular assays, KPV is primarily evaluated for its capacity to modulate inflammatory cascades without inducing the melanogenic actions associated with full-length α-MSH peptides.

Principal investigators and laboratory technicians select the 50mg bulk specification when running multi-plate cell culture assays, long-term cellular exposure models, or multi-subject animal research protocols where batch consistency across treatments is critical. Utilizing a single 50mg fill eliminates lot-to-lot variance during a continuous testing cycle, reducing potential confounders in quantitative biomarker assays.

PX1 Catalog Availability & Formatting Context

PX1 Research manufactures and distributes high-purity research peptides for institutional and laboratory use. While the 50mg vial format represents an optimized bulk scale for large-scale experimental designs, laboratories requiring standard lower-yield preparations for baseline assays frequently utilize our standard KPV 10mg vial format.

To review current inventory status, custom mass requests, or alternate unit quantities, researchers can inspect our complete offering via the all peptides catalog. All unit sizes, whether scaled for pilot studies or high-throughput screens, adhere to identical analytical purity thresholds and processing standards.

Molecular Structure and Preclinical Mechanism of Action

KPV exerts its primary biochemical effects by interacting with intracellular inflammatory signaling network pathways. Preclinical studies suggest that KPV enters target cells—such as intestinal epithelial cells and macrophages—via the specialized oligopeptide transporter PepT1 (SLC15A1). Once internalized, the tripeptide inhibits the translocation of nuclear factor kappa B (NF-κB) into the nucleus.

By blocking NF-κB nuclear translocation, KPV downregulates the transcriptional activation of key pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6. In vitro assays demonstrate that KPV acts as a potent inhibitor of inflammatory gene expression without binding directly to classical melanocortin receptors (MC1R–MC5R) with high affinity, thereby isolating its anti-inflammatory mechanism from pigmentary or steroidogenic signaling pathways.

Reconstitution Mathematics for 50mg Lyophilized Mass

Reconstituting a high-mass 50mg lyophilized cake requires accurate volumetric calculations to ensure precise delivery of microgram-level working doses. Because 50mg represents a substantial mass of peptide powder, laboratory staff must account for displacement volume and target concentration thresholds when selecting the volume of diluent (such as sterile bacteriostatic water or 0.9% sodium chloride).

Below are standard reconstitution reference points for a 50mg KPV vial:

• 1.0 mL Diluent Addition: Yields a final stock concentration of 50.0 mg/mL (50.0 µg/µL). • 2.0 mL Diluent Addition: Yields a final stock concentration of 25.0 mg/mL (25.0 µg/µL). • 3.0 mL Diluent Addition: Yields a final stock concentration of 16.67 mg/mL (16.67 µg/µL). • 5.0 mL Diluent Addition: Yields a final stock concentration of 10.0 mg/mL (10.0 µg/µL).

For complex dilution schemes, serial dilution planning, or unit conversion verification, researchers are advised to utilize the PX1 reconstitution calculator to minimize pipetting errors before preparing working solutions.

Aliquot Planning and Long-Term Laboratory Storage Protocol

Lyophilized KPV powder exhibits excellent physical stability when stored under controlled conditions. Upon arrival, un-reconstituted vials should be kept in a desiccated freezer environment at -20°C or -80°C, protected from light. Under these parameters, the dry peptide maintains chemical stability and purity for up to 24 months.

Once reconstituted, peptide solutions are prone to hydrolytic and enzymatic degradation if subjected to repeated freeze-thaw cycles or prolonged storage at room temperature. To maximize stability:

1. Allow the vial to equilibrate to room temperature before adding sterile diluent to prevent condensation inside the glass. 2. Gently swirl the vial until complete dissolution occurs; do not vortex vigorously to avoid peptide shear stress. 3. Immediately divide the stock solution into single-use, sterile polypropylene microcentrifuge tube aliquots. 4. Store working aliquots at -20°C (stable for up to 3 months) or -80°C (stable for up to 12 months). Avoid standard frost-free freezers due to temperature fluctuations.

Comparative Analysis: KPV vs. Related Inflammatory and Barrier Research Peptides

In intestinal barrier and mucosal inflammation research, investigators frequently evaluate KPV alongside other experimental compounds targeting mucosal repair and tight junction integrity. Understanding the distinct mechanisms of these compounds allows researchers to select the optimal model candidate.

While KPV functions via PepT1-mediated cellular uptake and intracellular NF-κB suppression, BPC-157 acts primarily through angiogenesis modulation, FAK-paxillin pathway activation, and growth factor upregulation. Concurrently, larazotide (AT-1001) serves as a tight-junction peptide antagonist, directly inhibiting zonula occludens-1 (ZO-1) rearrangement. Additionally, vasoactive intestinal peptide (VIP) operates through GPCR signaling to regulate immune cell differentiation and intestinal fluid secretion. KPV is unique among these options due to its ultra-small molecular weight (325.4 Da) and direct intracellular trans-epithelial transport mechanism.

In Vitro and In Vivo Research Applications: Intestinal Barrier Models

Preclinical studies evaluating KPV focus heavily on models of inflammatory bowel disease (IBD), ulcerative colitis, and compromised epithelial barrier function. In vitro data indicate that KPV added to Caco-2 cell monolayers challenged with pro-inflammatory cytokines preserves trans-epithelial electrical resistance (TEER) and prevents the downregulation of tight junction proteins Claudin-1 and Occludin.

In vivo animal studies utilizing dextran sulfate sodium (DSS)-induced or trinitrobenzene sulfonic acid (TNBS)-induced colitis in murine models demonstrate that local administration of KPV reduces histological inflammation scores, decreases neutrophil infiltration (measured via myeloperoxidase activity), and accelerates mucosal recovery. These findings position KPV as a primary candidate for studying target-specific intestinal anti-inflammatory mechanisms.

Analytical Quality Control: HPLC, Mass Spectrometry, and COA Verification

PX1 Research enforces strict quality control standards for every manufacturing lot. High-mass fills such as 50mg require stringent validation to confirm that purity and concentration remain uniform throughout the filling run.

Every batch undergoes high-performance liquid chromatography (HPLC) to confirm structural chemical purity (>98.0%) and liquid chromatography-mass spectrometry (LC-MS) to confirm precise molecular mass (325.4 g/mol). Furthermore, all lots are tested for bacterial endotoxins using Chromogenic Reagent Kinetic LAL assays, ensuring levels remain well under standard in vitro research thresholds (<0.01 EU/µg). Researchers can inspect lot-matched certificates of analysis directly through our dedicated COA verification system.

Selecting the Right Fill Format: Institutional Research Context

Choosing between a standard 10mg format and a high-yield 50mg format depends entirely on the design and scale of the research protocol. Small pilot trials, exploratory binding assays, or short-term tissue culture experiments generally benefit from smaller fill sizes to prevent excess reconstituted material from sitting in storage.

Conversely, high-throughput screening facilities, longitudinal rodent study designs, or multi-investigator projects benefit from the operational efficiency and cost-effectiveness of the 50mg format. For institutional procurement departments managing high-volume requirements, PX1 offers dedicated supply options through our wholesale program, guaranteeing synchronized lot numbers for extensive trial series. Additional educational literature and technical references are accessible via our central research hub.